Cover Image
市場調查報告書

白內障:全球臨床實驗檢討

Cataract Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 237451
出版日期 內容資訊 英文 79 Pages
訂單完成後即時交付
價格
Back to Top
白內障:全球臨床實驗檢討 Cataract Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月11日 內容資訊: 英文 79 Pages
簡介

本報告提供全球各國白內障治療藥物臨床實驗相關調查,各地區、進展狀況、各階段、各募集情況的實驗量,代表性贊助商,正在開發的治療藥物的資訊,各企業機關的進行狀況等資訊彙整,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 白內障
  • 報告指南
  • 臨床實驗 各地區
  • 臨床實驗 各國
  • - 亞太地區對臨床實驗有所貢獻的主要5個國家
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • - 中東及非洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 中南美
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 各臨床實驗狀態
  • 未完成的臨床實驗; 白內障
  • 每段時期的實驗人數
  • 有力的贊助商
  • 潛力治療藥物比較
  • 參加主要企業 - 白內障 治療藥物的臨床實驗
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Bausch & Lomb Incorporated
  • 臨床實驗概要; Bausch & Lomb Incorporated
  • ISTA Pharmaceuticals, Inc.
  • 臨床實驗概要; ISTA Pharmaceuticals, Inc.
  • Innovative Medical Products
  • 臨床實驗概要; Innovative Medical Products
  • Alcon Research Ltd.
  • 臨床實驗概要; Alcon Research Ltd.
  • Bucci Laser Vision
  • 臨床實驗概要; Bucci Laser Vision
  • Omeros Corporation
  • 臨床實驗概要; Omeros Corporation
  • Alcon, Inc.
  • 臨床實驗概要; Alcon, Inc.
  • Allergan, Inc.
  • 臨床實驗概要; Allergan, Inc.
  • Aurolab
  • 臨床實驗概要; Aurolab
  • LABORATOIRES THEA
  • 臨床實驗概要; LABORATOIRES THEA
  • InSite Vision Incorporated
  • 臨床實驗概要; InSite Vision Incorporated
  • The Chakshu Research, Inc.
  • 臨床實驗概要; The Chakshu Research, Inc.
  • Aqumen Biopharmaceuticals
  • 臨床實驗概要; Aqumen Biopharmaceuticals
  • Bp Consulting Inc
  • 臨床實驗概要; Bp Consulting Inc
  • ESBATech AG
  • 臨床實驗概要; ESBATech AG
  • 千壽製藥
  • 臨床實驗概要; 千壽製藥
  • Transcend Services, Inc.
  • 臨床實驗概要; Transcend Services, Inc.
  • Novartis AG
  • 臨床實驗概要; Novartis AG
  • Acucela Inc.
  • 臨床實驗概要; Acucela Inc.
  • Dean Health Systems, Inc.
  • 臨床實驗概要; Dean Health Systems, Inc.
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Iladevi Cataract and IOL Research Center
  • 臨床實驗概要; Iladevi Cataract and IOL Research Center
  • Medical University of South Carolina
  • 臨床實驗概要; Medical University of South Carolina
  • The Wenzhou Medical College
  • 臨床實驗概要; The Wenzhou Medical College
  • Indiana University School of Medicine
  • 臨床實驗概要; Indiana University School of Medicine
  • Veroia General Hospital
  • 臨床實驗概要; Veroia General Hospital
  • Federal University of Sao Paulo
  • 臨床實驗概要; Federal University of Sao Paulo
  • Johns Hopkins University
  • 臨床實驗概要; Johns Hopkins University
  • Karolinska Institutet
  • 臨床實驗概要; Karolinska Institutet
  • Sheba Medical Center
  • 臨床實驗概要; Sheba Medical Center
  • Sun Yat-sen University
  • 臨床實驗概要; Sun Yat-sen University
  • The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  • 臨床實驗概要; The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  • University of Sao Paulo
  • 臨床實驗概要; University of Sao Paulo
  • Carmel Medical Center
  • 臨床實驗概要; Carmel Medical Center
  • Frederiksberg Hospital
  • 臨床實驗概要; Frederiksberg Hospital
  • Hospital Hietzing
  • 臨床實驗概要; Hospital Hietzing
  • Dr. Ram Manohar Lohia Hospital
  • 臨床實驗概要; Dr. Ram Manohar Lohia Hospital
  • Samsung Medical Center
  • 臨床實驗概要; Samsung Medical Center
  • Tabriz University
  • 臨床實驗概要; Tabriz University
  • Chulalongkorn University
  • 臨床實驗概要; Chulalongkorn University
  • Medical University of Vienna
  • 臨床實驗概要; Medical University of Vienna
  • 主要5件臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 白內障 全球治療藥物市場, 臨床實驗 各地區
  • 白內障 全球治療藥物市場, 臨床實驗 各國排名
  • 白內障 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 白內障 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 白內障 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 白內障 治療藥物的臨床實驗, 北美, 主要國家
  • 白內障 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 白內障 治療藥物的臨床實驗, 中南美, 主要國家
  • 白內障 治療藥物的臨床實驗, 金磚四國 各國
  • 白內障 治療藥物的臨床實驗, G7 各國
  • 白內障 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 白內障 治療藥物的臨床實驗, E7 各國
  • 白內障 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 白內障 全球治療藥物市場, 各階段臨床實驗
  • 白內障 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 白內障 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 白內障 全球治療藥物市場, 暫時停止的臨床實驗
  • 白內障 全球治療藥物市場, 中止的臨床實驗
  • 白內障 全球治療藥物市場, 終止的臨床實驗
  • 白內障 全球治療藥物臨床實驗, 平均登計對象人數趨勢
  • 白內障 全球治療藥物臨床實驗, 主要的贊助商
  • 白內障 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • 白內障 全球治療藥物臨床實驗, 主要企業 各階段
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Bausch & Lomb Incorporated
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - ISTA Pharmaceuticals, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Innovative Medical Products
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Alcon Research Ltd.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Bucci Laser Vision
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Omeros Corporation
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Alcon, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Allergan, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Aurolab
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - LABORATOIRES THEA
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - InSite Vision Incorporated
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - The Chakshu Research, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Aqumen Biopharmaceuticals
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Bp Consulting Inc
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - ESBATech AG
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - 千壽製藥
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Transcend Services, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Novartis AG
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Acucela Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Dean Health Systems, Inc.
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Iladevi Cataract and IOL Research Center
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Medical University of South Carolina
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - The Wenzhou Medical College
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Indiana University School of Medicine
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Veroia General Hospital
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Federal University of Sao Paulo
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Johns Hopkins University
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Karolinska Institutet
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Sheba Medical Center
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Sun Yat-sen University
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - University of Sao Paulo
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Carmel Medical Center
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Frederiksberg Hospital
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Hospital Hietzing
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Dr. Ram Manohar Lohia Hospital
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Samsung Medical Center
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Tabriz University
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Chulalongkorn University
  • 白內障 全球治療藥物臨床實驗市場, 臨床實驗 - Medical University of Vienna

圖表一覽

圖表一覽

  • 白內障 全球治療藥物市場, 臨床實驗 各地區 (%)
  • 白內障 全球治療藥物市場, 臨床實驗 各國排名
  • 白內障 全球治療藥物市場, 進行中的臨床實驗 各國排名
  • 白內障 (%)治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 白內障 (%)治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 白內障 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • 白內障 (%)治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 白內障 治療藥物的臨床實驗, 中南美, 主要國家 (%)
  • 白內障 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 白內障 治療藥物的臨床實驗, G7 各國 (%)
  • 白內障 治療藥物市場, G7 各國, 臨床實驗 各臨床實驗狀態
  • 白內障 治療藥物的臨床實驗, E7 各國 (%)
  • 白內障 治療藥物市場, E7 各國, 臨床實驗 各臨床實驗狀態
  • 白內障 全球治療藥物市場, 各階段臨床實驗 (%)
  • 白內障 全球治療藥物市場, 進行中的臨床實驗 各階段
  • 白內障 全球治療藥物市場, 臨床實驗 各臨床實驗狀態
  • 白內障 全球治療藥物臨床實驗, 平均登計對象人數趨勢
  • 白內障 全球治療藥物臨床實驗, 主要的贊助商
  • 白內障 全球治療藥物臨床實驗, 臨床實驗, 各有潛力治療藥
  • 白內障 全球治療藥物臨床實驗, 主要企業 各階段
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2713CTIDB

GlobalData's clinical trial report, "Cataract Global Clinical Trials Review, H1, 2015" provides an overview of Cataract clinical trials scenario. This report provides top line data relating to the clinical trials on Cataract. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cataract
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cataract to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cataract
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cataract Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Cataract
      • Apr 20, 2015: Icon Bioscience Announces Pivotal Phase 3 Clinical Data Demonstrates Exceptional Efficacy of IBI-10090 in Reducing Inflammation Associated with Cataract Surgery
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Innovative Medical Products
      • Clinical Trial Overview of Innovative Medical Products
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • Laboratoires Thea S.A.
      • Clinical Trial Overview of Laboratoires Thea S.A.
      • InSite Vision Incorporated
      • Clinical Trial Overview of InSite Vision Incorporated
      • Bucci Laser Vision
      • Clinical Trial Overview of Bucci Laser Vision
      • Omeros Corporation
      • Clinical Trial Overview of Omeros Corporation
      • Bausch & Lomb Incorporated
      • Clinical Trial Overview of Bausch & Lomb Incorporated
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
    • Clinical Trial Overview of Top Institutes / Government
      • NHS Trusts Clinical Trials
      • Clinical Trial Overview of NHS Trusts Clinical Trials
      • Indiana University School of Medicine
      • Clinical Trial Overview of Indiana University School of Medicine
      • Moorfields Eye Hospital NHS Foundation Trust
      • Clinical Trial Overview of Moorfields Eye Hospital NHS Foundation Trust
      • Department of Health, UK
      • Clinical Trial Overview of Department of Health, UK
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Arak University of Medical Sciences
      • Clinical Trial Overview of Arak University of Medical Sciences
      • Capital Medical University
      • Clinical Trial Overview of Capital Medical University
      • Federal University of Sao Paulo
      • Clinical Trial Overview of Federal University of Sao Paulo
      • Het Oogziekenhuis Rotterdam
  • Clinical Trial Overview of Het Oogziekenhuis Rotterdam
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cataract Therapeutics, Global, Clinical Trials by Region, 2015*
  • Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Cataract Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Cataract Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Cataract Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Cataract Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Cataract Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Cataract Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Cataract Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Cataract Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Innovative Medical Products, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Thea S.A., 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by InSite Vision Incorporated, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bucci Laser Vision, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Omeros Corporation, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by NHS Trusts Clinical Trials, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Moorfields Eye Hospital NHS Foundation Trust, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Arak University of Medical Sciences, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital Medical University, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015*
  • Cataract Therapeutics Clinical Trials Market, Global, Clinical Trials by Het Oogziekenhuis Rotterdam, 2015*

List of Figures

  • Cataract Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Cataract Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Cataract Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Cataract Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Cataract Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Cataract Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Cataract Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Cataract Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Cataract to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Cataract Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Cataract Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Cataract to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Cataract Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Cataract Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Cataract Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Cataract Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Cataract Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Cataract Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Cataract Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Cataract Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Cataract Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top